Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi MSCI Europe Ex EMU ESG Selection UCITS ETF Acc

CU9 · FR0010821819 · EUR · domicile France
Equity · Europe · Sustainable / ESGSFDR art. 8
Index tracked: MSCI Europe ex EMU ESG Selection P-Series 5% Issuer Capped Index
TER
0.30%+ trans. 0.15%
Fund size
224 m EUR
Tracking difference
−0.36%3-year avg
🇮🇹 tax rate
white list not published
Replication
Physical
Income
Accumulating
Launch 15 Dec 2009 · costs from the KID as of 2 Sept 2026 · 104 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Fund is a passively managed UCITS. The Fund promotes environmental and/or social characteristics within the meaning of Article 8 of the Disclosure Regulation. By subscribing to Amundi MSCI Europe Ex EMU ESG Selection UCITS ETF, you are investing in a passively managed UCITS whose objective is to replicate as accurately as possible the performance of the MSCI Europe ex EMU ESG Selection P-Series 5% Issuer Capped Index (the "Index"), regardless of whether it experiences a positive or negative development. The maximum tracking error objective between…

Performance since series start (in euro) — base 100

10 Jul 20178 Sept 2026 · dividends reinvested where declared by the issuer
2018202020222024202618981186
High 189 (29 Jul 2026) · low 81 (23 Mar 2020) · last 186. Past performance is not indicative of future results.

Returns in euro

1 year+10.3%
3 years+30.4%
5 years+39.1%
10 yearsseries too young
Since series start+85.6%

Risk · 1 / 3 / 5 years

Volatility (ann.)12.08%12.03%12.91%
Max drawdown−10.57%−16.31%−16.31%
Sharpe0.670.520.39
Sortino0.980.710.53
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · CU9 · FR00108218191
RebalixCU9 · FR0010821819 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+8.50%+8.68%−0.18%
2024+7.70%+8.24%−0.54%
2023+12.58%+12.94%−0.37%
2022−6.74%−6.42%−0.33%
2021+27.82%+28.33%−0.51%

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 104 securities · top-10 weight = 41.5%
Top holdingsWeight
HSBC HOLDINGS PLC5.4%
NOVARTIS AG-REG5.1%
ASTRAZENECA GBP4.9%
NOVO NORDISK A/S-B4.9%
ABB LTD-REG4.4%
ZURICH INSURANCE GROUP AG4.2%
UNILEVER PLC LONDON4.1%
LLOYDS BANKING GROUP PLC3.4%
LONZA GROUP AG-REG2.8%
SPOTIFY TECHNOLOGY SA2.3%
Countries (% of fund)
United Kingdom39.8%Switzerland32.6%Sweden14.1%Denmark10.7%Norway2.8%
Sectors (% of fund)
Health Care25.7%Financials25.5%Industrials21.3%Consumer Staples8.5%Communication Services5.6%

Listing venues

ESMA register (FIRDS) and official exchange lists
· Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
CU9 · Euronext Paris
CU9GR · Xetra (Deutsche Börse)
+ 22 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/FR0010821819/ENG/DEU
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/FR0010821819/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/FR0010821819/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/FR0010821819
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · CU9 · FR00108218192